fiveonefour | $17,000,000 | (Sep 5, 2025)
Sesh Products | $40,000,000 | (Sep 5, 2025)
Pointsville | Undisclosed Amount | (Sep 5, 2025)
Certified by Founder
Lodge
Ochre Bio
start up
United Kingdom
- Oxford
- 11/10/2022
- Series A
- $30,000,000
Ochre Bio develops RNA therapies for chronic liver diseases, a leading cause of death globally.
Privately held, Ochre Bio is situated within the heart of Oxford’s biotech innovation hub. To learn more, please visit www.ochre-bio.com.
- Industry Biotechnology Research
- Website https://www.ochre-bio.com/
- LinkedIn https://www.linkedin.com/company/ochre-bio/
Related People
Jack O'MearaCo Founder
United Kingdom -
Oxford, England,
I help to get new medicines and healthcare technologies to patients.
Interested in the intersection of science, medicine, and business.
Augment | $85,000,000 | (Sep 5, 2025)
Plural(US) | $7,000,000 | (Sep 5, 2025)
Hello Patient | $22,500,000 | (Sep 5, 2025)
Euclid Power | $20,000,000 | (Sep 5, 2025)
Lead | $70,000,000 | (Sep 5, 2025)
Pave Finance | $14,000,000 | (Sep 5, 2025)
throxy (yc x25) | $6,200,000 | (Sep 5, 2025)
Human Behavior (YC X25) | $5,000,000 | (Sep 5, 2025)
FlexifyMe | $2,400,000 | (Sep 5, 2025)